The historical rank and industry rank for Asensus Surgical's Gross Margin % or its related term are showing as below:
FRA:2TX'
s Gross Margin % Range Over the Past 10 Years
Min: -173.07 Med: -53.38 Max: 32.91
Current: -52.04
During the past 13 years, the highestGross Margin % of Asensus Surgical was 32.91%. The lowest was -173.07%. And the median was -53.38%.
FRA:2TX's Gross Margin % is ranked worse than 97% of 800
companies
in the Medical Devices & Instruments industry
Industry Median: 53.135
vs FRA:2TX: -52.04
Asensus Surgical had a gross margin of -172.12% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Asensus Surgical was 0.00% per year.
Asensus Surgical Gross Margin % Historical Data
The historical data trend for Asensus Surgical's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Asensus Surgical's Gross Margin %
For the Medical Devices subindustry, Asensus Surgical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asensus Surgical's Gross Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Asensus Surgical's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Asensus Surgical's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Asensus Surgical had a gross margin of -172.12% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Asensus Surgical Gross Margin % Related Terms
Thank you for viewing the detailed overview of Asensus Surgical's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. The company's single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:2TX has been successfully added to your 